Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $23.6000 (1.46%) ($23.1000 - $23.8900) on Fri. Jun. 5, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.15% (three month average) | RSI | 45 | Latest Price | $23.6000(1.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.6% a day on average for past five trading days. | Weekly Trend | HALO declines -0.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(51%) IBB(50%) IWM(46%) IWC(44%) ARKG(43%) | Factors Impacting HALO price | HALO will decline at least -2.075% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-14%) TLT(-2%) IGOV(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.075% (StdDev 4.15%) | Hourly BBV | 0 () | Intraday Trend | 0.4% | | | |
|
Resistance Level | $23.98 | 5 Day Moving Average | $23.78(-0.76%) | 10 Day Moving Average | $23.94(-1.42%) | 20 Day Moving Average | $23.98(-1.58%) | To recent high | -4.9% | To recent low | 69.8% | Market Cap | $3.225b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |